Company intelligence / Profile preview

H2

Montgomery, Alabama, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

H2-Pharma is a privately held pharmaceutical company focused on the development, sales, and marketing of generic prescription and over-the-counter (OTC) products. The company specializes in identifying niche generic opportunities and managing the supply chain to bring cost-effective medications to the US market. Their portfolio spans multiple therapeutic categories, including gastroenterology, cardiovascular health, and pain management. H2-Pharma operates primarily through strategic partnerships with manufacturers and distributors to maintain a lean, efficient business model.

Therapeutic areas: CardiovascularNeurologyDermatologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Partnerships

Various contract manufacturing organizationsMajor US pharmaceutical wholesalers

Beyond the preview

Go deeper on H2.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on H2.

Explore the full profile